PATIENT SQUARE CAPITAL LP 13F Portfolio
PATIENT SQUARE CAPITAL LP runs PATIENT SQUARE CAPITAL LP and currently holds 23 stock positions, which is fewer than the average of 231 among the investors we track. The portfolio is valued at approximately $645.52M. Their top holdings are ROIV, RVMD, MIRM, ABVX, ONC. The top five represent 64.9% of reported portfolio weight. PATIENT SQUARE CAPITAL LP ranks #162 out of 1000 investors tracked by Alpha Score. In the most recent quarter, PATIENT SQUARE CAPITAL LP initiated 4 new positions. They added to 8 existing positions. They trimmed 7 positions. Their current best-performing preview position is RCUS with returns of +42.73%.
Portfolio Value
$645.52M
Alpha Score
101.2
#162 of 1000
Holdings
23
PATIENT SQUARE CAPITAL LP Current 13F Holdings
Reported holdings from PATIENT SQUARE CAPITAL LP's latest SEC 13F filing, ranked by portfolio weight.
23 stock holdings
| Holding | Weight | Avg Buy | Current | Return | Quarter Change |
|---|---|---|---|---|---|
 ROIV ROIVANT SCIENCES LTD | 43.97% | $9.01 | $35.44 | +293.34% | Trimmed -1.78% |
 RVMD REVOLUTION MEDICINES INC | 8.01% | $187.28 | $189.76 | +1.32% | New Buy |
 MIRM MIRUM PHARMACEUTICALS INC | 4.72% | $72.35 | $86.01 | +18.88% | Added +13.26% |
 ABVX ABIVAX SA | 4.26% | $104.87 | $88.15 | -15.94% | Added +70.32% |
 ONC BEONE MEDICINES LTD | 3.97% | $300.97 | $354.47 | +17.78% | Added +11.77% |
 PHVS PHARVARIS N V | 3.60% | $25.98 | $31.10 | +19.71% | Added +36.15% |
 ARGX ARGENX SE | 3.31% | $686.33 | $825.03 | +20.21% | Trimmed -37.36% |
 UTHR UNITED THERAPEUTICS CORP DEL | 3.12% | $541.83 | $549.16 | +1.35% | New Buy |
 COGT COGENT BIOSCIENCES INC | 2.55% | $36.91 | $31.00 | -16.01% | Trimmed -28.69% |
 XENE XENON PHARMACEUTICALS INC | 2.06% | $50.13 | $36.44 | -27.31% | Trimmed -3.08% |
Showing 1-10 of 23